Ratio Revelations: Aurinia Pharmaceuticals Inc (AUPH)’s Financial Metrics in the Spotlight

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed the day trading at $7.99 up 0.13% from the previous closing price of $7.98. In other words, the price has increased by $0.13 from its previous closing price. On the day, 1.04 million shares were traded.

Ratios:

For a better understanding of AUPH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.11. For the most recent quarter (mrq), Quick Ratio is recorded 5.26 and its Current Ratio is at 5.93. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.18.

Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Keenan Greg sold 8,305 shares for $8.23 per share. The transaction valued at 68,350 led to the insider holds 153,484 shares of the business.

Greenleaf Peter sold 195,593 shares of AUPH for $1,564,744 on Mar 03 ’25. The Chief Executive Officer now owns 1,953,892 shares after completing the transaction at $8.00 per share. On Mar 04 ’25, another insider, Greenleaf Peter, who serves as the Chief Executive Officer of the company, sold 164,947 shares for $7.92 each. As a result, the insider received 1,306,380 and left with 1,788,945 shares of the company.

Valuation Measures:

As of this moment, Aurinia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.93, and their Forward P/E ratio for the next fiscal year is 10.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.37 while its Price-to-Book (P/B) ratio in mrq is 3.14.

Stock Price History:

Over the past 52 weeks, AUPH has reached a high of $10.67, while it has fallen to a 52-week low of $5.11. The 50-Day Moving Average of the stock is -0.72%, while the 200-Day Moving Average is calculated to be 1.78%.

Shares Statistics:

A total of 137.75M shares are outstanding, with a floating share count of 120.13M. Insiders hold about 11.08% of the company’s shares, while institutions hold 44.92% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.